Antibioti::s are "non-essential" metabolites, since an organism can flourish wi1hout producing them, and their usefulness to the organism, which is still not clear, e.g. ref.
I, is at any rate marginal. They represent a considerabl·~ consumption of materials and energy, and appear to draw usually on t!1.e same pools ofprecursors which are required for moreessential structural ü)mponents such as amino-acids, carbohydrates, nucleotides, and con1pounds found in energy-producing cycles, such as acetyl coenzyme-A.
Antibioti1: production by an organism depends on a complex sequence of processes. The precursors must often be in a suitably activated state, i.e. in the form of derivatives such as pyrophosphates or coenzyme-A esters. The activating e 1zymes and coenzymes must also be developed by the organism, and. their synthesis represents a considerable additional consumption of pre•::ursors a nd energy.
The chen List who tends to think in terms of stimulating production of a contpound hy feeding a normal biosynthetic intermediate may be greatly ove:r-simplifring the problem, as can be seen by a consideration of biosyw:hetic pr )Cesses.
Biosynthe;is probably proceeds at defined centres inside the cell and an exogenaus ~ubstance must therefore be able to penetrate into the cell. Passage of a substance from the growth medium is not usually a process of simple diffu~ion but of "active" ·transfer: consequently, the cell may reject entirely some compounds offered to it even though these may be genuine biosynthetic intermediates. For example, isopentenylpyrophosphate is a known intermediate in polyterpene synthesis, but is not normally taken up fror:1 the m< dium. In order to utilize it the cell membranes h. ve to be disrup1:ed and the enzymes released, clearly not a feasible process for production purposes.
The term "intermediate" is also often used very loosely to include substances whi( h contain the molecular fragment which is ultimately incorporated, e.g. acetic acid. In fact, such precursors are involved in an activated forn1 in con Lbination with a coenzyme or carrying extra groups such as pyrophosphate. In order for such an "intermediate" to participate, therefore, even if it penetrates the cell wall, it must be provided in suitably activated form, or the cell must be capable of activating it. In the case of the isopentenylpyrophosphate (I, R = pyrophosphate) it is useless to feed isopentenol (I, R = H) since there is no biochemical mechanism for phosphorylating it.
The pyrophosphate group is normally introduced at the stage ofmevalonic acid (II) which therefore usually can be utilized as a terpene intermediate. "Active" acetic acid is acetyl coenzyme-A ( or malonyl coenzyme-A produced by its reversible carboxylation) and is not usually produced biochemically from acetic acid itself, but from carbohydrate metabolism. However, acetic acid is taken up by many organisms and is found to be activated enzymatically; it therefore behaves as a genuine intermediate in appropriate cases. The true intermediate, acetyl coenzyme-A, is not usually absorbed from the medium and can only be artificially incorporated using disintegrated cell systems.
In many cases, even when the compound fed is incorporated as shown by radioactive tracer experiments, it may have no noticeable effect in stimulating production. Alternatively, compounds with no apparent chemical relation to the antibiotic may have a marked effect on production, possibly because of effects on enzyme-production, energy-release, or suppression of alternative pathways.
Antibiotic production in a cell is only one aspect of a series of complex interrelated processes in a dynamic biochemical situation. The inhibition of one series of pathways, particularly that connected with the production of structural materials, may release "energy", i.e. molecules such as ATP, and precursors, to stimulate others such as the production of secondary metabolites. Theseare frequently produced in largest amount when some growth precursors are in short supply at the end of the growth phase of a particular culture. Alternatively, stimulation of a process may occur by the addition of a coenzyme or precursor of a coenzyme or enzyme which is in short supply. Some strains of Penicillium brevi-compactum for example, show greatly enhanced yields ofmycophenolic acid (III) when given methionine, the coenzyme necessary for the 0 and C-methylation processes which are involved in the biosynthesis of (III). Many biosynthetic intermediates, if they can l1e obtained at all, are difficult to make and expensive, so that for normal a1 Ltibiotic production their addition is unlikely to be economical even if yields are increased.
The lin~.iting factors to antibiotic yields are in any case frequently not directly rei_ated to the supply ofa given precursor. In a complex biosynthetic process ce ~tain stages may be rate-limiting, and if the precursors involved could be detected and could be supplied they might be capable ofincreasing producÜoH. Since the rate of formation is dependent on enzyme as well as substra1:e < oncentration, a favourable effect may result from induced enzyme formaticm in the presence of added precursor, which may well explain the gibberelli< acid results below.
The fa< tors which apply to the stimulation of formation of a natural antibiotic by providing a normal intermediate should apply also to the productiml of a new antibiotic by feeding a modified intermediate, with an in1portant addition. Competition will occur between the normal endogenous intermediate, to give the normal antibiotic, and the abnormal exogenous intermediate to give a new one. If the enzymes can deal at all with the r1ew series they might be expected to do so more slowly, although this migh1 be countered in practice by a high concentration of the added compound. To remove this competition it should, in principle, be possible to mutate the organism so that it cannot complete the synthesis of the antibiotic unl<ss given the normal precursor, which the mutant therefore cannot make, but can utilize. Provided it can utilize at all the altered intermediate, the mutant should then be able to complete the synthesis of the new antibiotic witl no competitive formation ofthe natural one. This kind ofprocess should be easier to operate if the intermediate is of a chemical type not directly related to normal metabolism and if the antibiotic is built up in one piece whi< h can be synthetically imitated and then further converted, or in several pi< ces which are later joined. If the intermediate is directly related to norr:J.a] metabolism, as in the side-chain precursors of penicillins, the approach may be more difficult, since, for example, the production of· phenylalanine could not be stopped without severe effects on growth. However, the division between "normal" and "abnormal" precursors may be rather indLstinct. In the case of benzylpenicillin, for example, although the precursor (phenylacetyl coenzyme-A) is related to phenylalanine metabolism, it seems to be normally derived from components of the growth medium, and by appropriate choice of medium the penicillin precursor, arninopenicillanic acid, lacking the side chain, accumulates. The selection of strains < f organisms and of media, hitherto made in a very empirical manner, might be mademorerational on the basis of such considerations.
In ordel' to have a biochemical basis for attempts at manipulation, either to prod'~C< more of a known antibiotic or an altered antibiotic, it is necessary to know a~ intimately as possible the details of the normal routes involved in biosynthesis.
The types of processes involved in the assembly of simple units vary trom those whi< h, although they involve a sequence of reactions, do not permit isolation o :-stable intermediates, to those which involve separate elaboration of stable rr olecules which are eventually linked or modified. Methods which have prov~d fruitful so far in the investigation of such sequences in mould metabolites are the incorporation of isotopically labelled, preferably radioactive, precursors, and the production of mutants. A further method, involving isolation of the enzymes involved, has so far made little progress except in restricted fields.
The tracer method, based on thorough degradations of the antibiotics to enable examination of the detailed fates of atoms in the precursors, usually enables the origins of the skeletal atoms to be defined, and in conjunction with considerations of reaction mechanisms may permit guesses about intermediatestobe tested. The mutant method may in favourable cases permit arrest of the synthetic process and isolation of intermediates, but has experimental drawbacks. Since the compounds are non-essential metabolites there is no automatic method of choosing appropriate mutants which must be laboriously screened by chemical or spectroscopic methods. Moreover, where unstable intermediates are produced which are linked to enzymes or coenzymes until the process reaches the stage of a biochemically irreversible compound, interruption of the process before this stage may result merely in reversion to the precursor units. From work on the anthraquinone islandicin, which is a polyketide derived from "acetate" units, the construction of the skeleton is probably an all-or-nothing process in this category 2 • It appears that other polyketides, whether derived from "acetate" or "propionate", such as the tetracyclines and macrolides, may be in the same dass.
Examination of minor metabolites as in the case of griseofulvin3 and gib berellic acid4, or of series of closely related compounds as in the actidione series5 has often given important clues. Co-metabolites may themselves be intermediates, for example (-)-kaurene in the case of gibberellic acid, or may mark minor deviations from the main route which are nevertheless informative.
Having defined a route as exactly as possible, it then remains to attempt to use the information either to stimulate production or to form an altered antibiotic. How this can be clone depends very much on the type of process involved, and is best illustrated by examples, not all of antibiotics.
GIBBERELLIC ACID
Biogenetically this compound (V) produced by Gihherella fujikura is terpenoid, as shown by its origin from [14C]-acetic acid and [14C]-mevalonic acid (II) 6, the specific terpene precursor. An ou tline of the process is shown opposite. Theseare extremely specific processes and it therefore seems unlikely that compounds of different structure or stereochemistry could be utilized. However, yields might be increased by feeding normal intermediates. (-)-Kaurene (IV) is incorporated and its addition leads to increased yields. _Feeding of mevalonic acid, which is the first biochemically irreversible precursor, affects production considerably. When added to the culture medium gibberellic acid production begins much sooner and proceeds much more rapidly in the initial stages7. The final concentration is rather higher, but the important fact is that a similar yield can be obtained in a much shorter time, thus making more economical use of capital equipment. Whether this is commercially interesting depends on complex questions of cost.
Mutation of this or similar organisms may lead to altered products either
by modification of the specificity of the enzymes, or more readily by complete disn:ption of stages, such as secondary oxidations which are not directly co 1cerned with the construction of the main skeleton. I t has been suggested8 that all the diterpenes of plants and moulds may be the result of acciden1al modifications of the synthetic process leading to the "target molecule" gibberellic acid. The only compounds which might be readily A. ]. BIRCH obtained with the gibberellic acid skeleton are, on this basis, derivatives of a lower degree of oxidation. It may seem astanishing that a hydrocarbon like kaurene can be utilized by addition to the fermentation but it may be taken up by surface Iipids. The biochemical oxidations of exogenaus steroids by many organisms, which are efficient industrial processes, are equally astonishing. ·
PENICILLIN
The classical case illustrating the scope and limitations of precursor addition is that of the penicillins. Several natural penicillins (VI, R = COR') occur with different acid side chains which indicates that the probable precursor is the base (VI, R = H) which is acylated, rather unspecifically, by some acyl coenzyme-A derivatives. By feeding foreign acids, such as phenoxyacetic acid9, new semi-synthetic penicillins can be obtained, (e.g., VI, R = COCH 2 0C6H 5 ). The range of these is rather limited, since two enzymic specificities are involved: activation ofthe acid to its coenzyme-A ester, and acylation of the amino-group. These can be avoided by carrying out the fermentation in the absence ofside-chain precursor, when the aminoacid (VI, R = H) itself can be obtained and acylated chemically with almost any acid.
The natural coenzyme-A ester, for example, of phenylacetic acid, is probably not derived from the free acid, but from phenylpyruvic acid derived from phenylalanine by oxidative deamination. It might in some cases, therefore, be possible to decrease further the enzymic specificity of the activation stage by using, not the acid itself, but the homologaus IX-keto-acid. Recent work 10 using S-methylcysteine and methionine in an attempt to affect the nucleus led instead to penicillins (e.g. VI, R = CHaSCH2CH2CO) with acyl side-chains derived from the added amino-acids by oxidative decarboxylation in this way. Similar types of process might be much more generally useful in cases where acylations are involved. It is, therefore, necessary to think in terms of the most probable precursor of the desired activated entity, which may differ from the entity itself (cf. fumagillin below).
So far there has been no success whatever in attempts to modify the penicillin nucleus by precursor feeding. To produce it a complex series of oxidations must occur in the cysteinylvaline portion of a peptidell, with production of two new bonds, presumably sequentially, but simultaneously in the sense that no intermediate with one extra bond has been detected. All such processes seem to be highly structure-specific, in cantrast to processes such as acylation or formation of glycosides where some structural latitude seems possible. Other cases occur of antibiotics where similar enzymic Iack of specificity can be argued from the frequent occurrences of mixtures of related compounds: for example, the actinomycins (VIII) in which the peptide portion varies in composition, and the antimycin-A complex (IX) in which occur different ester groups, and mixed alkyl sidechains12, the latter ultimately derived from homologaus normal fatty acids. In agreement with the idea oflower specificity it has been shown that feeding some foreign amino-acids produces incorporation into the actinomycin peptide chain 1 3. How far this is possible with other peptide antibiotics remains to be discovered. It migh!: be possible to modify the nucleus of substances like penicillin ehher by 1 he unlikely process of modifying the enzymes by mutation, or by metabolisr1 ofthe normal antibiotic by some other organism, since a number of oxidation processes in particular seem to be substrate-unspecific. A natural modification of the nucleus is found in cephalosporin-C (VII) wi:1ich could weil be due to an alteration in Cephalosporium of the oxidation process fm md in Penicillium, using the same peptide but with several extra stages. Mutations required' to do this would involve modification of enzymes and addition offurther ones, and seem far less likely tobe deliberately ac:hieved 1 han the mutations involving lass of a synthetic stage considered below.
TETRACYCLINES
A differ·~nt use, in principle, of biogenetic information is illustrated by the tetracydines, such as Terramycin (X). In this case we predicted in 195414, and lat•er :onfirmed by tracer experiments15, that the nucleus is mainly or wholly ·Df 1he polyketide type with an introduced C-Me and N-Me (from methionin ~) with ancillary oxidation, reduction stages, and introduction of nitrogen as shown schematically below. Later work16, tends to show that the polykftide chain is initiated at the CONH2 end, probably as malonyl coenzyrne-A or its amide.
The ::1udear C-Me creates a centre of chemical instability in the molecule, a:1d it appeared desirable to derive some method of omitting it, although 1 he effect of this on biological activity was unknown. On the basis ofthe biosynthesis shown, two methods might work: to mutate the organism to disrup1. the C-methylation stage, or to add inhibitors of methionine methylati<•n. The latter seemed unlikely, since N-methylation would also presumably have to take place. The mutation process would involve simply destroy.ng the production of an enzyme, not modifying it, and therefore appeared a likely process. An alternative biosynthetic hypothesis, related to Woodward's "propionate" hypothesis 1 7 would have been that the C-Me was C-3 <f a propionate unit (biochemically methylmalonyl coenzyme-A) and its ornission would require modification of an enzyme to deal with malonyl cDenzyme-A instead, a much less likely result of mutation than destrucüon of an enzyme. Later work independently, and apparently empiricallr, did find a strain of organism which produces desmethyltetracyclirle commerciallyls. Also independent consideration of biochernica.l olteration of the methylation stage led to the use of sulphonamides19 and of ethionine20. The former lead to desmethyltetracycline, so there is a lower sens1.tivity shown by the N-methylating enzyme; the latter Ieads to an even rnor·~ interesting result, ornission of the C-Me accompanied by insertion c f one Et on the nitrogen to NHEt.
Similar modifications of methylation are at least possible with other antibiotics such as the actinomycins and novabioein containing "introduced" lVIe grours. However, an attempt to inhibit the methylation of mycophenolic acidwas unsuccessful21, Alterati)n of the skeleton at some intermediate biosynthetic stage might of course Jtave disrupted the whole process, resulting in no productat all if the substrate specificity of the enzymes associated with later stages had been completely linked to the normal structures.
Further minor modifications of the tetracycline nucleus might be possible through mutations which inhibit oxidations and reductions. For example, the "extra" (non-acetate) oxygens might be omitted, or the "missing" acetate oxygen from the 8-position of ring-D (XI), the removal of which must result from reduction of a carbonyl group in a non-aromatic intermediate, might be restored by disruption of this process. This assumes that completion of the biosynthesis is possible with such altered intermediates, which may not be so. There is strong evidence22 also that some of the "introduced" oxygen (in ring-C) is necessarily there in connection with the conversion of an aromatic ring into a dienone, (XII) prior to reduction; it may therefore necessarily be present because of the mechanism involved.
Carrying over this idea to the other rings, it appeared that probably alt of the "introduced" oxygen might be present because of a similar oxidative "de-aromatization" of a fully aromatic precursor. reported23 in which fully aromatic precursors such as (XIII) have been converted into 7-chlorotetracyclines by feeding to a mutant of Streptomyces aureofac2ens. The 6-desmethyl analogue similarly gave rise to the desmethyl se~ies. It is also interesting that the NMe2 group is apparently introduced at this stage. As predicted by the polyketide origin, it therefore seems likely that it is 1•ossible to produce the erid-product only by feeding a substance with a contplete ring-system. The :proctical developments of this topic have obviously not depended or. the the·)retical considerations above, but the deductions were made and if applied could have probably facilitated the developments. They are quoted to ~ how the type of r:easoning which might be useful in other cases.
It is in1eresting also that many polyketides show evidence of lack of enzymic specificity in the nature of the first unit of the chain 24 , and this applies als) to the tetracyclines. In many of the plant acylphloroglucinols the acyl ~ide-chain varies considerably and evidently derives from the coenzyme-A esters of acids such as acetic, isobutyric, isovaleric, a-methylbutyric attd cinnamic; in some cases complex mixtures recur. A cometabolite of Terramycin is (XIV) which on this view would be derived by a :;eparate route from a chain initiated by acetoacetyl coenzyme-A instead of malonyl coenzyme-A. I t is possible that the proportion of this might be in·:reased l1y an additional source ofthe former, such as butyric acid; sources of other ß-ketoacid esters might produce analogues.
NOVOBIOCIN
A mc-re classical case of alteration of an antibiotic is novabioein (XV). The present evidence for the origin of this substance is that the aminocoumar:.n (B) comes from tyrosine by oxidative cyclization, the methyl being derived from methionine; the acid (A) from tyrosine and presumably a C5-unit; the sugar (C) directly from glucose and methionine. The acylaniinocour 1arin is built up, possibly with insertion of the nuclear Me as the last stage, and the glycosidic linkage then formed. Addition of the acid corresponding to (A) increases the yield under defined conditions25; moreover other related acids usually containing p-OH, OMe or NH2 give analogaus cmnpounds which however, have no, or much reduced, activity. We have furtl er found that synthetic acylaminocoumarins such as the phydroxy be 1zoyl are converted into analogues. The enzymic specificity of tho~ stage concerned with introduction of the sugar seems tobe relatively low, and since ·he acylaminocoumarins are readily synthesized a series of compounds could be made. We might expect that the series which can be obtained should belarger than when the acids themselves are fed, since the specificitie concerned with the acylation stage are avoided.
FUMAGILLIN
This sub ;tance (XVI) 26 has a terpenoid nucleus and a fatty acid type sidechain 27. A ny attempts to produce altered antibiotics must rest on a knowledge of hcw to obtain the activated precursors. The precursor of the side chain is pr;~sumably the monocoenzyme-A ester (XVII) in the natural case, not deriven from the dicarboxylic acid itself, since feeding [1-1 4 C]-acetic acid gives the side-chain labeHing shown in (XVI). The authentic precursor may therefore be (XVIII) converted by oxidation directly into (XVII). It probably would be useless on this view to feed synthetic dicarboxylic acids and expect them to be incorpora ted.
Much of the foregoing is speculation, but, I believe, on a sound basis. Sufficient information is becoming available about fundamental aspects of biosynthesis to make possible intelligent attempts to manipulate the processes. In the past such attempts have been very largely empirical. There is still far too little known about the more biochemical aspects of the formation of secondary mould metabolites and it seems to me desirable to make a broad approach in this field, rather than a narrow one concerned with one or two antibiotics, even from the short-term point of view of modification of antibiotics.
